CMS Retires NCD 343: What the Home Oxygen / Cluster Headache Coverage Shift Means for Your DME Billing

The Centers for Medicare & Medicaid Services (CMS) has officially retired National Coverage Determination (NCD) 343, which previously governed Medicare coverage of home oxygen therapy for the treatment of cluster headaches. This retirement—effective September 27, 2021, and formalized through the NCD Manual revision issued March 9, 2023—shifts coverage authority away from a single national standard and into the hands of regional Medicare Administrative Contractors (MACs). For billing teams and RCM directors managing durable medical equipment claims, this change means the rules covering these patients are no longer uniform across the country.

What CMS NCD 343 Was — and Why Its Retirement Matters for DME Billing

NCD 343 was Medicare's national-level coverage determination for the use of home oxygen to treat cluster headaches. Under the NCD system, a single CMS determination applied uniformly to all Medicare beneficiaries across the country, giving billing teams a consistent standard to reference when documenting medical necessity and submitting claims.

When CMS retires an NCD, it does not mean the service is categorically non-covered. It means CMS has decided to step back from setting a national standard—and that decision-making authority reverts to each region's MAC under Section 1862(a)(1)(A) of the Social Security Act.

This is a meaningful structural shift. Before the retirement, a biller in Texas and a biller in New York could reference the same NCD when justifying a home oxygen claim for a cluster headache patient. Post-retirement, those same billers now need to look to their respective MACs—Novitas Solutions and CGS Administrators, respectively—for guidance.

How MAC-Level Coverage Determinations Work After an NCD Retirement

When CMS removes an NCD, MACs are authorized to make their own local coverage determinations (LCDs) or apply general coverage rules under the Social Security Act's "reasonable and necessary" standard. In the absence of both an NCD and a specific LCD, MACs apply individual claim-level medical necessity review.

For home oxygen therapy specifically, CMS directs MACs to the guidance found in Chapter 1, Section 240.2 (Home Use of Oxygen), Subsection D of Publication 100-03 of the NCD Manual. That section outlines the broader framework for how home oxygen is evaluated under Medicare's DME benefit category—but it does not automatically reinstate coverage for cluster headaches. It simply provides the analytical structure MACs must use.

In practical terms, this means:

• Your MAC may have issued, or may eventually issue, a Local Coverage Determination (LCD) specific to oxygen therapy for cluster headaches
• In the absence of an LCD, individual claims will be reviewed under general medical necessity standards
• Documentation requirements and prior authorization thresholds may differ significantly by jurisdiction

Cluster Headache and Home Oxygen: The Clinical and Billing Context

Cluster headache is a recognized neurological condition characterized by severe, unilateral head pain occurring in cyclical patterns. High-flow inhaled oxygen (typically 100% O2 at 7–15 liters per minute via non-rebreather mask) has been used as an acute abortive treatment and is referenced in clinical literature as effective for a subset of patients.

Under the retired NCD framework, coverage for this use was nationally defined. With NCD 343 gone, billing teams can no longer point to a single authoritative CMS document to support these claims. Instead, coverage hinges on:

1. Whether your MAC has issued a specific LCD covering oxygen for cluster headache
2. Whether the treating physician's documentation meets your MAC's medical necessity criteria for home oxygen under the general DME benefit
3. Whether the patient's diagnosis and treatment history are thoroughly documented in the medical record

This puts significantly more weight on clinical documentation than before. A claim that might have sailed through under NCD 343 may now face more intensive review under MAC-level discretion.

Affected Codes

This policy does not list specific CPT, HCPCS, or ICD-10 codes. The retired NCD 343 falls under the Durable Medical Equipment benefit category, and code applicability is now determined at the MAC level. Billing teams should consult their regional MAC's LCD database for applicable HCPCS codes related to home oxygen equipment and any associated diagnosis code requirements specific to cluster headache.

Prior Authorization and Documentation Considerations

NCD 343's retirement does not introduce a new federal prior authorization requirement—but that does not mean prior auth is off the table. MACs retain the authority to impose prior authorization requirements under their local policies, and some already do for home oxygen equipment.

At minimum, your documentation should be prepared to support:

• A confirmed diagnosis of cluster headache, supported by clinical notes from a treating neurologist or qualified physician
• Evidence that the prescribing physician has determined home oxygen to be medically necessary for acute treatment
• Prescription details including flow rate, frequency of use, and duration
• Any prior treatments attempted and their outcomes

Given that coverage is now discretionary at the MAC level, robust documentation is your primary defense in the event of a claim review or audit.

What Your Billing Team Should Do